Community-Based Harm Reduction Programs for Opioid Use Disorder: A Narrative Systematic Review of Effectiveness, Implementation Barriers, and Policy Implications
ASIDE Internal Medicine · 11.07.2026 · 3 (2) · 41-55
DOI: 10.71079/aside.im.071126729 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift ASIDE Internal Medicine, online erschienen am 11.07.2026. Verfasst von Eloghosa Aisosaa Nosa-Ihaza und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Background
This systematic review synthesizes evidence on community-based harm reduction programs and their role in addressing the opioid crisis.
Methods
A narrative synthesis was conducted of 78 studies published between January 2012 and April 2023; meta-analysis was precluded by heterogeneity across interventions, populations, and outcomes. Eligible designs included quantitative observational studies, qualitative/mixed-methods studies, program evaluations, and existing systematic/scoping reviews. Interventions examined included syringe service programs (SSPs), overdose education and naloxone distribution (OEND), overdose prevention centers (OPCs), drug-checking services, and low-barrier medications for opioid use disorder (MOUD). Outcomes included overdose mortality, infectious disease transmission, treatment linkage, and feasibility/acceptability.
Results
OEND scale-up was associated with reduced opioid overdose mortality at county and state levels. SSPs were consistently linked to reduced HIV and HCV transmission. OPCs reported no on-site fatal overdoses despite high volumes of supervised consumption. Integrated SSP-MOUD models improved MOUD initiation and retention, though association strength varied by setting and design. Combined approaches showed favorable cost-effectiveness. Persistent barriers included punitive paraphernalia laws, regulatory constraints, stigma, and rural service gaps.
Conclusion
Key gaps remain in implementation science, longitudinal efficacy of newer interventions (OPCs, drug-checking), and stigma-reduction strategies. Policy implications include integrating harm reduction into mainstream health infrastructure via sustained funding, deregulation to expand providers, mobile/mail-based rural access, and public communication to build legitimacy. Across a heterogeneous evidence base, community-based harm reduction consistently associates with reduced overdose mortality and infectious disease burden. Translating this evidence into equitable, sustainable implementation remains the central challenge for public health policy and practice.
Zitieren
APA
Nosa-Ihaza, E. A., & Ssembuusi, A. F. (2026). Community-Based Harm Reduction Programs for Opioid Use Disorder: A Narrative Systematic Review of Effectiveness, Implementation Barriers, and Policy Implications. ASIDE Internal Medicine, 3(2), 41-55. https://doi.org/10.71079/aside.im.071126729
Vancouver
Nosa-Ihaza EA, Ssembuusi AF. Community-Based Harm Reduction Programs for Opioid Use Disorder: A Narrative Systematic Review of Effectiveness, Implementation Barriers, and Policy Implications. ASIDE Internal Medicine. 2026;3(2):41-55. doi:10.71079/aside.im.071126729
BibTeX
@article{NosaIhaza2026,
author = {Nosa-Ihaza, Eloghosa Aisosaa and Ssembuusi, Allan Francis},
title = {Community-Based Harm Reduction Programs for Opioid Use Disorder: A Narrative Systematic Review of Effectiveness, Implementation Barriers, and Policy Implications},
journal = {ASIDE Internal Medicine},
year = {2026},
volume = {3},
number = {2},
pages = {41--55},
doi = {10.71079/aside.im.071126729}
}
EUVIMED